Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas F O'Donnell

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|September 25, 2020
Degradation of lymphatic anatomy and function in early venous insufficiencyJohn C Rasmussen, Banghe Zhu, John R Morrow, et al.
Journal of Translational Medicine|September 29, 2011
The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial designEric Benoit, Thomas F O'Donnell, Mark D Iafrati, et al.
Journal of the American College of Cardiology|April 15, 2014
Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart diseaseJacob A Udell, David A Morrow, Petr Jarolim, et al.
Phlebology|March 8, 2022
The American Venous Forum, American Vein and Lymphatic Society and the Society for Vascular Medicine expert opinion consensus on lymphedema diagnosis and treatmentFedor Lurie, Rafael D Malgor, Teresa Carman, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|September 25, 2020
Degradation of lymphatic anatomy and function in early venous insufficiencyJohn C Rasmussen, Banghe Zhu, John R Morrow, et al.
Journal of Translational Medicine|September 29, 2011
The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial designEric Benoit, Thomas F O'Donnell, Mark D Iafrati, et al.
Journal of the American College of Cardiology|April 15, 2014
Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart diseaseJacob A Udell, David A Morrow, Petr Jarolim, et al.
Phlebology|March 8, 2022
The American Venous Forum, American Vein and Lymphatic Society and the Society for Vascular Medicine expert opinion consensus on lymphedema diagnosis and treatmentFedor Lurie, Rafael D Malgor, Teresa Carman, et al.
Pageof 5